Amended Statement of Ownership (sc 13g/a)
January 17 2018 - 9:21AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
FORTRESS
BIOTECH, INC.
|
(Name of Issuer)
|
Common Stock, $0.001 par value per share
|
(Title of Class of Securities)
|
34960Q 109
|
(CUSIP Number)
|
December 31, 2017
|
(Date of Event Which Requires Filing of this Statement)
|
Check the appropriate box to designate the
rule pursuant to which this Schedule is filed:
*The remainder of this cover page shall be
filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of
this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934
(“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however, see the Notes).
CUSIP No. 34960Q
109
|
|
|
|
1.
|
Names of Reporting Persons.
|
|
|
I.R.S. Identification Nos. of above persons (entities only)
|
|
|
|
|
|
Mr. Daryl Katz
|
|
|
|
|
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
|
|
(a)
|
|
|
(b)
|
|
|
|
|
|
|
|
3.
|
SEC Use Only
|
|
|
|
|
|
|
|
4.
|
Citizenship or Place of Organization Canada
|
|
|
|
|
|
|
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
|
5.
|
Sole Voting Power 0
|
|
|
|
|
6.
|
Shared Voting Power 4,755,371
|
|
|
|
|
7.
|
Sole Dispositive Power 0
|
|
|
|
|
8.
|
Shared Dispositive Power 4,755,371
|
|
|
|
|
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person 4,755,371
|
|
|
|
|
|
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
|
|
|
|
|
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9) 9.39%
|
|
|
|
|
|
|
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
IN
|
|
|
|
CUSIP No. 34960Q
109
|
|
|
|
1.
|
Names of Reporting Persons.
|
|
|
I.R.S. Identification Nos. of above persons (entities only)
|
|
|
|
|
|
DAK Capital Inc.
|
|
|
|
|
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
|
|
(a)
|
|
|
(b)
|
|
|
|
|
|
|
|
3.
|
SEC Use Only
|
|
|
|
|
|
|
|
4.
|
Citizenship or Place of Organization Canada
|
|
|
|
|
|
|
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
|
5.
|
Sole Voting Power 0
|
|
|
|
|
6.
|
Shared Voting Power 4,755,371
|
|
|
|
|
7.
|
Sole Dispositive Power 0
|
|
|
|
|
8.
|
Shared Dispositive Power 4,755,371
|
|
|
|
|
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person 4,755,371
|
|
|
|
|
|
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
|
|
|
|
|
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9) 9.39%
|
|
|
|
|
|
|
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
CO
|
|
|
|
CUSIP No. 34960Q
109
|
|
|
|
1.
|
Names of Reporting Persons.
|
|
|
I.R.S. Identification Nos. of above persons (entities only)
|
|
|
|
|
|
DAK Investments Corp.
|
|
|
|
|
|
|
|
2.
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
|
|
|
|
(a)
|
|
|
(b)
|
|
|
|
|
|
|
|
3.
|
SEC Use Only
|
|
|
|
|
|
|
|
4.
|
Citizenship or Place of Organization Canada
|
|
|
|
|
|
|
Number of
Shares Beneficially
Owned by Each
Reporting
Person With:
|
5.
|
Sole Voting Power 0
|
|
|
|
|
6.
|
Shared Voting Power 0
|
|
|
|
|
7.
|
Sole Dispositive Power 0
|
|
|
|
|
8.
|
Shared Dispositive Power 0
|
|
|
|
|
|
|
9.
|
Aggregate Amount Beneficially Owned by Each Reporting Person 0
|
|
|
|
|
|
|
|
10.
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
|
|
|
|
|
|
|
|
11.
|
Percent of Class Represented by Amount in Row (9) 0.00%
|
|
|
|
|
|
|
|
12.
|
Type of Reporting Person (See Instructions)
|
|
|
CO
|
|
|
|
Item 1.
(a) Name of Issuer
Fortress Biotech, Inc. (the “
Issuer
”)
(b) Address of Issuer’s Principal Executive
Offices
3 Columbus
Circle, 15th Floor, New York, New York 10019
Item 2.
(a) Name of Person Filing
Mr. Daryl Katz (“
Mr. Katz
”)
DAK Capital Inc.
(“
DAK
”)
DAK Investments Corp. ("
DAK
Investments
" and together with DAK and Mr. Katz, the “
Reporting Persons
”).
(b) Address of Principal Business Office or, if none,
Residence
The principal business
address of each Reporting Person is:
1702 Bell Tower, 10104 -103 Avenue
Edmonton, AB , Canada T5J 0H8
(c) Citizenship
Mr. Katz is a citizen of Canada.
DAK is a corporation formed under the
laws of Alberta, Canada.
DAK Investments is a corporation formed
under the laws of Alberta, Canada.
(d) Title of Class of Securities
Common Stock, $0.001 par value per share, of the Issuer
(the “
Common Stock
”).
(e) CUSIP Number
34960Q 109
Item 3. If this statement is filed pursuant
to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
Not applicable.
Item 4.
Ownership.
(a), (b) and (c):
Reference is hereby made to Items 5
– 9 and 11 of pages 2 – 4 of this Schedule, which Items are incorporated by reference herein.
|
(a)
|
Amount Beneficially Owned:
|
Mr.
Katz - 4,755,371 shares
DAK
- 4,755,371 shares
DAK
Investments - 0 shares
Mr.
Katz - 9.39%
DAK
-9.39%
DAK
Investments - 0.00%
|
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
sole power to vote or to direct the vote
|
Mr.
Katz - 0 shares
DAK
- 0 shares
DAK
Investments - 0 shares
|
(ii)
|
shared power to vote or to direct the vote
|
Mr.
Katz - 4,755,371 shares
DAK
- 4,755,371 shares
DAK
Investments - 0 shares
|
(iii)
|
Sole power to dispose or to direct the disposition of
|
Mr.
Katz - 0 shares
DAK
- 0 shares
DAK Investments - 0 shares
|
(iv)
|
shared power to dispose or to direct the disposition of
|
Mr.
Katz - 4,755,371 shares
DAK
- 4,755,371 shares
DAK
Investments - 0 shares
|
Item 5.
|
Ownership of Five Percent or Less of a Class
|
Not applicable.
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person
|
Not
applicable
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported
on By the Parent Holding Company
|
Not applicable.
|
Item 8.
|
Identification and Classification of Members of the Group
|
Not applicable.
|
Item 9.
|
Notice of Dissolution of Group
|
Not applicable.
Item 10. Certification
By signing below I certify
that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection
with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry
and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: January 9, 2018
|
/s/ Mr. Daryl Katz
|
|
|
Mr. Daryl Katz
|
|
|
|
|
|
|
DAK CAPITAL INC.
|
|
|
|
|
|
|
By:
|
/s/ Mr. Daryl Katz
|
|
|
|
Mr. Daryl Katz, President
|
|
|
|
|
|
|
DAK INVESTMENTS CORP.
|
|
|
|
|
|
|
By:
|
/s/ Mr. Daryl Katz
|
|
|
|
Mr. Daryl Katz, President
|
|
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Fortress Biotech (NASDAQ:FBIO)
Historical Stock Chart
From Apr 2023 to Apr 2024